Guidance for industry : minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies.
| Other author | Center for Biologics Evaluation and Research (U.S.) |
| Format | Electronic |
| Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2006] |
| Description | ii, 46 p. : digital, PDF file |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS112475 |
| Subjects |
| Portion of title | Minimally manipulated, unrelated, allogeneic placental/umbilical cord blood intended for hematopoietic reconstitution in patients with hematological malignancies |
| General note | Title from PDF title page (viewed on May 11, 2009). |
| General note | "Draft guidance." |
| General note | "December 2006". |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| Bibliography note | Includes bibliographical references (p. 46). |
| Technical details | Mode of access: Internet at the FDA CBER web site. Address as of 5/11/09: http://www.fda.gov/cber/gdlns/cordbld.pdf ; current access is available via PURL. |
| GPO item number | 0499-T-02 (online) |
| Govt. docs number | HE 20.4802:C 81/2 |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |